Ki-CONNECT(Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy)
Ki-CONNECT, a dedicated center with a 30-bed ward, leads the development of innovative medical treatments to success under the full support of our qualified medical staff in conducting the early clinical studies for patients requiring iPS cell regenerative therapy, as well as those with cancer or other intractable diseases. Proof of concept (POC) study and first in human/class study are our main targets.